[Date Prev] | [Thread Prev] | [Thread Next] | [Date Next] -- [Date Index] | [Thread Index] | [List Home]
Subject: PROFILE IMGM IMAGIN MOLECULAR CORP.
IMGM: Imagin Molecular Corp. An Explosive Opportunity as the U.S. Medical Imaging Market Nears $7 Billion The medical imaging equipment market in the U.S. will register gains of 7.6 percent per year through 2008 to 9.5 billion, faster than projected growth in national health expenditures. Growth will be stimulated by an increasing incidence of patient procedures involving diagnostic imaging, partly the result of and aging population and partly reflecting advances in innovative imaging technology. Our featured company IMGM through its wholly owned subsidiary Imagin Nuclear Partners is a full service joint venture molecular imaging partner with a business model based on owning, operating, and administering out-patient medical diagnostic imaging centers that utilize PET and PET/CT (computed tomography) scanning equipment. IMGM'S TARGET MARKET IMGM's target market is community hospitals which comprise 81% of the overall U.S. hospital market and private medical imaging practices. IMGM seeks to create joint ventures that own, operate, and manage Positron Emission Tomography (PET) diagnostic imaging centers within these hospitals. By creating these in house imaging centers, these hospitals can recapture revenue that is often lost or outsourced to independent medical diagnostic entities. 7 Day Price and Volume as of 1/6/2006 CORPORATE SNAPSHOT Imagin Molecular Corp. (OTCBB: IMGM) is a Deleware corporation headquartered in Oak Brook, IL that is dedicated to business opportunities in the area of Positron Emission Tomography (PET). PET is a diagnostic technology used in oncology, cardiology, and neurology. WHAT IS PET IMAGING Positron Emission Tomography (PET) is a powerful imaging technique that holds great promise in the diagnosis and treatment of many diseases, particularly cancer, heart disease, and neurological disorders. A non-invasive test, PET scans accurately image the cellular function of the human body. In a single PET scan your physician can examine your entire body. PET scanning provides a more complete picture, making it easier for your doctor to diagnose problems, determine the extent of disease, prescribe treatment, and track progress. STRATEGIC ALLIANCE IMGM through its other wholly owned subsidiary PAC owns a 64 million share convertible preferred note in Positron Corporation (OTCBB: POSC) with an approximate market value of $6 million upon conversion. Positron Corporation engages in the design, manufacturing, marketing, and servicing of advanced medical imaging devices using PET technology. INVESTMENT CONSIDERATIONS
|
[Date Prev] | [Thread Prev] | [Thread Next] | [Date Next] -- [Date Index] | [Thread Index] | [List Home]